Immune cells fighting chronic infections become progressively 'exhausted,' ineffectiveOctober 19, 2007Potential interventions to restore disease-fighting capability outlined (PHILADELPHIA) - A new study of immune cells battling a chronic viral infection shows that the cells, called T cells, become exhausted by the fight in specific ways, undergoing profound changes that make them progressively less effective over time. The findings also point to interventions that would reverse the changes, suggesting that novel therapies could be developed to reinvigorate T cells that become depleted in their struggle against a virus. Alternatively, strategies that would intentionally trigger the immune-dampening mechanisms explored in the study could prove useful in countering autoimmune disorders in which the immune system is inappropriately activated.
Although the experiments were conducted in mice, the problem of T-cell exhaustion has also been identified in HIV, hepatitis B, and hepatitis C infections in humans, as well as some cancers, such as melanoma. A report on the study results appears in the current issue of Immunity, published online October 18. "We knew that T cells responding to chronic infections become progressively compromised in many of their functional properties," says E. John Wherry, Ph.D., an assistant professor in the Immunology Program at The Wistar Institute and lead author on the Immunity study. "Put simply, the T cells become exhausted as time passes. What we wanted to learn in our study was what the specific problems were with these cells and whether their depleted state could be reversed." Using a technique called gene-expression profiling, Wherry and his colleagues identified 490 genes whose activity in T cells is altered during a chronic viral infection. Closer study at different time points using a 22-gene subset of the larger group of genes provided molecular signatures of progressive T-cell exhaustion. Only a few changes in the activity of the 22 genes were seen at the end of the first week of infection, increasing to 9 differences at two weeks, 18 differences at one month, and 21 differences at two months. At the end of two months, T cells contending with a chronic infection were sluggish metabolically and immunologically unresponsive to stimulus. One gene identified as playing a central role in this process is called PD-1, which codes for an inhibitory receptor on the surface of the T cells. By blocking PD-1 in vivo, the researchers found they could alleviate T-cell exhaustion, get more functional T cells, and control the infection better. "Blocking this one pathway partially reverses T-cell exhaustion in some settings, suggesting that we may be able to intervene to reinvigorate depleted immune cells," says Wherry. "The T cells undergo many changes during chronic infections, however, so that it will be important to learn how to treat them for multiple problems." Wherry notes that the mechanisms involved in T-cell exhaustion also have important upsides. "The flip side of this process is that the immune system has developed an effective way to turn off its response to a stimulus - which is exactly what one wants to do in the case of autoimmunity," he says. He points out, too, that the energy outlay during the acute phase of the immune system's response to an infection is enormous - and fundamentally unsustainable. "In the first week of an immune response to a virus, T cells can divide every four to six hours, as fast as any other mammalian cell at any time during development," Wherry says. "In terms of their rate of division, T cells are in the same category as cells in the earliest stages of embryonic development. The energy involved in doing this is extraordinary, and the body can't keep that up for an extended period of time." The Wistar Institute | |||||||||||||||||||||
|
Related Chronic Infection News Articles Infection Blocks Lung's Protective Response Against Tobacco Smoke An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Trapping white blood cells proves novel strategy against chronic viral infections Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found. Early treatment is key to combating hepatitis C virus Canadian researchers have shown that patients who receive early treatment for Hepatitis C virus (HCV) within the first months following an infection, develop a rapid poly-functional immune response against HCV similar to when infection is erradicted spontaneously, according to a new study published in the Journal of Virology. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide. Tooth loss strongly linked to risk of esophageal, head and neck, and lung cancer Studying thousands of patients, Japanese researchers have found a strong link between tooth loss and increased risk of three cancers - esophageal, head and neck, and lung. They suggest that preservation of teeth may decrease risk of developing these diseases. Research identifies first method for testing, assessing drug treatments for Chagas' disease Chagas' disease is a tropical parasitic sickness that currently affects more than 16 million people, with a staggering 100 million at risk, largely in the tropical areas of South and Central America. And yet the main drug used to treat the disease is highly toxic and causes serious side effects. Grapefruit compound may help combat hepatitis C infection A compound that naturally occurs in grapefruit and other citrus fruits may be able to block the secretion of hepatitis C virus (HCV) from infected cells, a process required to maintain chronic infection. New insights into vaccination for HIV A group of Australian researchers at the Universities of Melbourne and New South Wales have developed new tools and paradigms to understand immune evasion from HIV. Most UK citizens susceptible to hepatitis B infection The failure of the UK to introduce universal hepatitis B immunisation means that most UK citizens are susceptible to infection, warns an infectious diseases expert in this week's BMJ. More Chronic Infection News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||